Global Coagulation/Hemostasis Analyzers Market to Reach $7 Billion by 2027
Amid the COVID-19 crisis, the global market for Coagulation/Hemostasis Analyzers estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at a CAGR of 8.7% over the period 2020-2027. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$5.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing Analyzers segment is readjusted to a revised 10.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.8% CAGR
The Coagulation/Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.
Select Competitors (Total 41 Featured):
Amid the COVID-19 crisis, the global market for Coagulation/Hemostasis Analyzers estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at a CAGR of 8.7% over the period 2020-2027. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$5.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing Analyzers segment is readjusted to a revised 10.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.8% CAGR
The Coagulation/Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.
Select Competitors (Total 41 Featured):
- Alere, Inc.
- Diagnostica Stago SAS
- Helena Laboratories, Inc.
- Instrumentation Laboratory
- Nihon Kohden Corporation
- Roche Diagnostics (Schweiz) AG
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
Frequently Asked Questions about the Global Market for Coagulation/Hemostasis Analyzers
What is the estimated value of the Global Market for Coagulation/Hemostasis Analyzers?
What is the growth rate of the Global Market for Coagulation/Hemostasis Analyzers?
What is the forecasted size of the Global Market for Coagulation/Hemostasis Analyzers?
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
III. MARKET ANALYSIS
IV. COMPETITION
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- Coagulation/Hemostasis Analyzer: A Prelude
- Steady Growth Projected for Coagulation/Hemostasis Analyzers Market
- Established Use Case and Technology Improvements Sustain Market Momentum
- Impact of Covid-19 and a Looming Global Recession
- Rising Awareness about Blood Clots as the Root of Major Health Issues Fuels Growth in the Coagulation/Hemostasis Analyzer Market
- Venous Thromboembolism, a Blood Clot that Starts in a Vein
- Rising Prevalence of Cardiovascular Diseases and Related Mortality Rates Widen Prospects for Coagulation/Hemostasis Analyzers
- Exhibit 1: Leading Causes of Mortality Worldwide (2016): Number of Deaths in Thousands by Cause
- Exhibit 2: Leading Causes of Mortality in Low-Income Countries (2016): Crude Death Rate (per 100,000 Population) by Cause
- Exhibit 3: Leading Causes of Mortality in High-Income Countries (2016): Crude Death Rate (per 100,000 Population) by Cause
- Exhibit 4: Global Cardiology and Cardiac Surgery Market: Revenues in US$ Billion for the Years 2019 and 2025
- Exhibit 5: Global Cardiac Surgery Market (2019): Percentage Breakdown of Revenues by Region
- Aging Global Population at High Risk of Blood Clots and Cardiac Illnesses: A Primary Driver
- Exhibit 6: Global 60+ Population by Geographic Region for the Years 2017 and 2050
- Exhibit 7: Top Countries with Highest Proportion of 60+ Population for the Years 1980, 2017 and 2050
- Clinical Coagulation Analyzers: The Dominant Segment
- High Performance Coagulation Stations Gain Traction in Lab-based Hemostasis Analysis
- POC Coagulation Analyzers Segment Exhibits Fast Paced Growth
- Fully Automated Coagulometers Come to Fore to Suffice Automation Strategies of Modern Laboratories
- A Peek into Laboratory Automation Trends Worldwide
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 41
Note: Product cover images may vary from those shown